Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders.
Vyome Holdings stock last closed at $1.92, down 0.52% from the previous day, and has decreased 65.09% in one year. It has overperformed other stocks in the Biotechnology industry by 0.09 percentage points. Vyome Holdings stock is currently +9.71% from its 52-week low of $1.75, and -70.73% from its 52-week high of $6.56.
At the moment, there are 7.02M HIND shares outstanding. The market capitalization of HIND is $13.48M. In the past 24 hours, 9000 HIND shares were traded.
You need a brokerage account to access the NASDAQ market and buy HIND shares.
In our opinion, eToro is the best brokerage. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, the next step is to fill out some personal details so you can invest in HIND today.
Now that you have finished signing up on the best free stock trading app, you can securely and quickly fund your account:
Check out the walkthrough below if you need help transferring money into your new brokerage account.
Once you have identified the best place to buy Vyome Holdings stock, it's important to evaluate their stock before you invest, so you can understand the risk and opportunity.
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on HIND's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge HIND's fair value.
Using relative valuations ratios:
You can access more valuation research on HIND's stock here.
Out of 1 sell side analysts who give ratings on HIND, the consensus analyst rating on Vyome Holdings is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Vyome Holdings stock forecast page.
Over the past year, executives and large shareholders at HIND have not bought or sold any shares.
Learn more about who owns HIND stock here.
No, Vyome Holdings doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two primary types of orders:
Press the Open Trade button and your broker will execute the order.
If you need additional assistance investing in stocks on eToro, watch the how to video below:
Now that you own some HIND stock, you'll want to stay up-to-date on your investment.
Put HIND on a watchlist to track the most important metrics related to your HIND stock.
To summarize, here are the 6 steps for buying Vyome Holdings stock:
If you need a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Vyome Holdings, add HIND to your watchlist by clicking the button below.